Literature DB >> 30575697

Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery.

Shane D'Souza1,2, Rathi Guhadasan2,3, Rebecca Jennings4, Sarah Siner4, Stéphane Paulus2, Kent Thorburn4, Christine Chesters4, Colin Downey5, Paul Baines4, Steven Lane6, Enitan Carrol2,4.   

Abstract

OBJECTIVES: Following surgery, it is difficult to distinguish a postoperative inflammatory reaction from infection. This study examined the predictive value of the biomarkers; procalcitonin, C-reactive protein, lactate, neutrophils, lymphocytes, platelets, and the biphasic activated partial thromboplastin time waveform in diagnosing bacterial infection following cardiac surgery.
DESIGN: Prospective, observational study.
SETTING: A regional, PICU in the United Kingdom. PATIENTS: Three-hundred sixty-eight children under the age of 16 admitted to the PICU for elective cardiac surgery were enrolled in the study.
INTERVENTIONS: All biomarker measurements were determined daily until postoperative day 7. Children were assessed for postoperative infection until day 28 and divided into four groups: bacterial infection, culture-negative sepsis, viral infection, and no infection. We used the Kruskal-Wallis test, chi-square test, analysis of variance, and area under the curve in our analysis.
MEASUREMENTS AND MAIN RESULTS: In total, 71 of 368 children (19%) developed bacterial infection postoperatively, the majority being surgical site infections. In those with bacterial infection, procalcitonin was elevated on postoperative days 1-3 and the last measurement prior to event compared with those without bacterial infection. The most significant difference was the last measurement prior to event; 0.72 ng/mL in the bacterial infection group versus 0.13 ng/mL in the no infection group (for all groups; p < 0.001). Longitudinal profiles of all biomarkers were indistinct in the bacterial infection and nonbacterial infection groups except in those with culture-negative infections who had distinct procalcitonin kinetics on postoperative days 1-4. Children with culture-negative sepsis required longer ventilatory support and PICU stay and were more likely to develop complications than the other groups.
CONCLUSIONS: None of the biomarkers studied within 3 days of infection distinguished between infection and postoperative inflammatory reaction. However, procalcitonin kinetics peaked on postoperative day 2 and fell more sharply than C-reactive protein kinetics, which peaked at postoperative day 3. The monitoring of procalcitonin kinetics following cardiac surgery may help guide rational antimicrobial use.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30575697     DOI: 10.1097/PCC.0000000000001826

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  4 in total

1.  Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study.

Authors:  Sara Bobillo-Perez; Iolanda Jordan; Patricia Corniero; Monica Balaguer; Anna Sole-Ribalta; Maria Esther Esteban; Elisabeth Esteban; Francisco Jose Cambra
Journal:  PLoS One       Date:  2019-06-17       Impact factor: 3.240

2.  Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial.

Authors:  Cherry-Ann Waldron; Emma Thomas-Jones; Jolanta Bernatoniene; Lucy Brookes-Howell; Saul N Faust; Debbie Harris; Lucy Hinds; Kerenza Hood; Chao Huang; Céu Mateus; Philip Pallmann; Sanjay Patel; Stéphane Paulus; Matthew Peak; Colin Powell; Jennifer Preston; Enitan D Carrol
Journal:  BMJ Open       Date:  2022-01-25       Impact factor: 2.692

3.  Title NMR-based metabolic profiling provides diagnostic and prognostic information in critically ill children with suspected infection.

Authors:  Arturas Grauslys; Marie M Phelan; Caroline Broughton; Paul B Baines; Rebecca Jennings; Sarah Siner; Stephane C Paulus; Enitan D Carrol
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

Review 4.  Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review.

Authors:  Jef Willems; Eline Hermans; Petra Schelstraete; Pieter Depuydt; Pieter De Cock
Journal:  Paediatr Drugs       Date:  2020-11-10       Impact factor: 3.022

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.